Overview
Portfolio
More
Brooksmgt Group
Lehi, United States
Healthcare-specific venture capital and private equity focusing on providing capital and strategic management to nascent companies preparing to commercialize products.
Portfolio
10+
Employees
N/A
Founded
2019
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Brooksmgt Group
Healthcare-specific venture capital and private equity focusing on providing capital and strategic management to nascent companies preparing to commercialize products.
Portfolio
10+
Employees
N/A
Founded
2019
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 8 of 8 matched portfolio companies
Epistemix offers a simulation platform that models the spread of diseases, ideas, and behaviors within populations, utilizing a cloud-based engine for scalable analysis. This technology enables organizations to evaluate potential impacts of interventions and make informed decisions in public health and resource allocation.
Funding: $14.7M
Rough estimate of the amount of funding raised
Funding: $14.7M
Rough estimate of the amount of funding raised
Geneial provides unified healthcare data infrastructure that automates data standardization and streamlines patient engagement workflows for research. The platform uses intelligent automation to convert disparate medical data into innovation-ready formats for diagnostics and therapeutic development. This results in significantly higher participation rates and accelerates the delivery of clean, structured data to researchers.
InSite Health provides outpatient therapy and psychiatric services for children, teens, and adults through a hybrid model of in‑person clinics and a secure telehealth platform. It partners with K‑12 school districts to embed licensed clinicians on campus, offering on‑demand counseling, crisis assessments, and data‑driven reporting, while also delivering virtual care across multiple states.
PathologyWatch provides a cloud‑based digital dermatopathology platform that captures whole‑slide images, integrates with EMR/EHR systems via HL7, and delivers results through secure clinician and patient portals. The solution enables dermatology practices to order tests, view high‑resolution slides, and obtain specialist second opinions online, reducing turnaround time and administrative overhead.
The startup provides infusion and injection services tailored for patients with complex chronic conditions, utilizing private suite settings to enhance patient comfort and care. By collaborating with the healthcare community, the company aims to lower healthcare costs while delivering personalized healthcare and caregiver services.
Funding: $40.0M
Rough estimate of the amount of funding raised
Funding: $40.0M
Rough estimate of the amount of funding raised
Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.
Funding: $186.0M
Rough estimate of the amount of funding raised
Funding: $186.0M
Rough estimate of the amount of funding raised
This company develops a coin-sized, fully-implanted neurostimulator that delivers automatic stimulation to peripheral nerves. Their device targets nerves like the tibial nerve to treat chronic conditions such as urge urinary incontinence, potentially reducing the risk of cardiovascular disease and stroke.
Wellsheet utilizes machine learning to create a Smart EHR user interface that organizes and prioritizes clinical data, enabling clinicians to access relevant patient information efficiently. This technology reduces the time spent on electronic health record management, thereby decreasing clinician burnout and improving patient care throughput.
Funding: $10.1M
Rough estimate of the amount of funding raised
Funding: $10.1M
Rough estimate of the amount of funding raised
Showing 2 of 2 unmatched portfolio companies